{"url":"https://lda.senate.gov/api/v1/filings/545b9892-7b35-40b9-9e4f-e2fe9d914c83/","filing_uuid":"545b9892-7b35-40b9-9e4f-e2fe9d914c83","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/545b9892-7b35-40b9-9e4f-e2fe9d914c83/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Irene Bueno","dt_posted":"2016-10-20T16:54:02.300000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1640 Rhode Island Ave. NW, Suite 700","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":76833,"url":"https://lda.senate.gov/api/v1/registrants/76833/","house_registrant_id":35960,"name":"NVG, LLC","description":"Government Relations Firm","address_1":"1640 Rhode Island Ave. NW","address_2":"Suite 700","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BETH ANNE COLE","contact_telephone":"+1 202-540-1070","dt_updated":"2026-07-30T15:56:39.439824-04:00"},"client":{"id":169095,"url":"https://lda.senate.gov/api/v1/clients/169095/","client_id":1002614,"name":"THERANOS, INC.","general_description":"Consumer healthcare technology company.","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitoring issues related to laboratory developed tests (LDTs)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":10172,"prefix":null,"prefix_display":null,"first_name":"JANE","nickname":null,"middle_name":null,"last_name":"LOEWENSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to CLIA","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":10172,"prefix":null,"prefix_display":null,"first_name":"JANE","nickname":null,"middle_name":null,"last_name":"LOEWENSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}